SELLAS Life Sciences SLS
NASDAQ SLS
$11.51 -0.08 (-0.69%)
At close: Sep 29, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) FCF Margin (2012 - 2022)

Updated

SELLAS Life Sciences' FCF Margin came in at -2380.90% for FY2022, down 2038.52 percentage points from -342.38% in FY2021.

Analysis

SELLAS Life Sciences (SLS) FCF Margin (2012 - 2022) Analysis & Trends

Going back to FY2013, SELLAS Life Sciences' FCF Margin data covers 5 years.

  • The FY2022 figure represents the lowest annual FCF Margin in data going back to FY2013.
  • Per Business Quant, earlier years put FCF Margin at -342.38% in FY2021 (+205.88 pp) and -548.26% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 SELLAS Life Sciences 2.34 Bn 2.34 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -715.00%
Jun 30, 2021 -257.79%
Mar 31, 2021 -180.16%
Dec 31, 2020 180.21%
Jun 30, 2015 -351.69%
Mar 31, 2015 -438.40%
Dec 31, 2014 -430.11%
Sep 30, 2014 -687.28%
Jun 30, 2014 -556.80%
Mar 31, 2014 -371.38%
Dec 31, 2013 -734.59%
Sep 30, 2013 -499.20%
Jun 30, 2013 -305.58%
Mar 31, 2013 -245.33%
Sep 30, 2012 -355.98%
API Access

SELLAS Life Sciences FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=SLS&period=max&api_key=YOUR_API_KEY